← Back to Search
1-(2-Mercaptobenzenesulfonyl)-3-hydroxyguanidines--novel Potent Antiproliferatives, Synthesis And In Vitro Biological Activity.
Kamil Brożewicz, J. Sławiński
Published 2012 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
Twenty four 1-[2-alkylthio-5-(azol-2 or 5-yl)-4-chlorobenzenesulfonyl]-3-hydroxyguanidines 6a-x have been synthesized in order to evaluate their biological activity. Compounds 6a, 6c, 6d, 6f, 6g, 6i-p, 6r-t, and 6v-x were tested for their in vitro anticancer activity at the US National Cancer Institute. The highest in vitro anticancer activity was found for compounds 6d, 6g and 6k with GI(50) average value in the range 1.62-1.86 μM, and TGI mean values 3.72-4.47 μM, whereas the remaining compounds showed broad spectrum of anticancer activity at low micromolar GI(50) level against all tested cancer cell lines. These results were subjected to CoMSIA analysis to establish quantitative structure-activity relationships. The results evidence that potency of these compounds correlates mainly with hydrophobic and polar surface properties of substituents located both at 2 and 5 positions of 1-(4-chlorobenzenesulfonyl) moiety of investigated 3-hydroxyguanidine series.
This paper references
Isoform-selective substrates of nitric oxide synthase.
Qiang Jia (2003)
Synthesis and anti-HIV-1 integrase activities of 3-aroyl-2,3-dihydro-1,1-dioxo-1,4,2-benzodithiazines.
Z. Brzozowski (2009)
Cancer chemotherapeutic agents
W. Foye (1995)
Synthesis of a new series of 4-chloro-2-mercapto-5-methylbenzenesulfonamide derivatives with potential antitumor activity.
J. Sławiński (2004)
Phase II trial of the novel sulphonylurea sulofenur in advanced breast cancer
D. Talbot (2004)
Synthesis, molecular structure, and in vitro antitumor activity of new 4-chloro-2-mercaptobenzenesulfonamide derivatives.
J. Sławiński (2005)
Significant activity of a novel cytotoxic agent, LY295501, against a wide range of tumors in the human tumor cloning system.
S. Diab (1999)
Synthesis, structural characterization, and in vitro antitumor activity of novel N-(6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)arylsulfonamides.
Z. Brzozowski (2007)
Synthesis and in vitro activity of novel 2-(benzylthio)-4-chloro-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamide derivatives
Kamil Brożewicz (2012)
Synthesis and cytotoxic evaluation of substituted sulfonyl-N-hydroxyguanidine derivatives as potential antitumor agents.
J. W. Chern (1997)
Efficacy of sulofenur and a second generation diarylsulfonylurea, N‐[5‐(2,3‐dihydrobenzofuryl) sulfonyl]‐N'‐(3,4‐dichlorophenyl)urea (LY295501), against colon adenocarcinoma xenografts
P. Houghton (1995)
New colorimetric cytotoxicity assay for anticancer-drug screening.
Philip Skehan (1990)
Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors.
C. Kuo (2004)
Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.
K. Paull (1989)
Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model
M. Dewar (1985)
Synthesis and Cytotoxicity of Oleanolic Acid/N-aryl-N'-hydroxyguanidine Hybrids
L. Chen (2010)
Synthesis, anti-HIV-1 integrase, and cytotoxic activities of 4-chloro-N-(4-oxopyrimidin-2-yl)-2-mercaptobenzenesulfonamide derivatives.
Z. Brzozowski (2008)
Studies on 1,2,4-benzothiadiazine 1,1-dioxides VII1 and quinazolinones IV2: synthesis of novel built-in hydroxyguanidine tricycles as potential anticancer agents
J. Chern (1993)
An Information-Intensive Approach to the Molecular Pharmacology of Cancer
J. Weinstein (1997)
N-Aryl N'-hydroxyguanidines, a new class of NO-donors after selective oxidation by nitric oxide synthases: structure-activity relationship.
A. Renodon-Cornière (2002)
Synthesis and antitumor activity of novel N'-(2-benzylthiobenzenesulfonyl)-1H-pyrazole-1-amidine derivatives
Jarosław Sławiński (2011)
Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics
V. Viswanadhan (1989)
Evidence for mitochondrial localization of N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)urea in human colon adenocarcinoma cells.
P. Houghton (1990)
Synthesis and in vitro antitumor activity of novel series 2-benzylthio-4-chlorobenzenesulfonamide derivatives.
J. Sławiński (2006)
ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES
J. Gasteiger (1980)
Prodrug design for the potent cardiovascular agent Nω-hydroxy-L-arginine (NOHA): synthetic approaches and physicochemical characterization.
D. Schade (2011)
This paper is referenced by
Preparation and Characterization of Zwitterionic Poly(β‐cyclodextrin‐co‐guanidinocitrate) Hydrogels for Ciprofloxacin Controlled Release
A. Heydari (2017)
Synthesis and Anti-Breast Cancer Evaluation of Novel N-(Guanidinyl)benzenesulfonamides
M. Ghorab (2014)
Oxadiazole-An Important Bioactive Scaffold for Drug Discovery and Development Process Against HIV and Cancer- A Review
Davinder Kumar (2019)
Novel 3-Amino-6-chloro-7-(azol-2 or 5-yl)-1,1-dioxo-1,4,2-benzodithiazine Derivatives with Anticancer Activity: Synthesis and QSAR Study
A. Pogorzelska (2015)
Novel 2-benzylthio-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamides with anticancer activity: Synthesis, QSAR study, and metabolic stability.
J. Sławiński (2017)
Preliminary investigation of anticancer activity by determining the DNA binding and antioxidant potency of new ferrocene incorporated N,N',N″-trisubstituted phenylguanidines.
R. Gul (2014)
Design, synthesis, and evaluation of novel ursolic acid derivatives as HIF-1α inhibitors with anticancer potential.
K. Chi (2017)
1‐(2‐Mercaptobenzenesulfonyl)‐3‐hydroxyguanidines — Novel Potent Antiproliferatives, Synthesis and in vitro Biological Activity.
Kamil Brożewicz (2013)
Novel 5-Substituted 2-(Aylmethylthio)-4-chloro-N-(5-aryl-1,2,4-triazin-3-yl)benzenesulfonamides: Synthesis, Molecular Structure, Anticancer Activity, Apoptosis-Inducing Activity and Metabolic Stability
B. Żołnowska (2016)
Novel 2-(2-alkylthiobenzenesulfonyl)-3-(phenylprop-2-ynylideneamino)guanidine derivatives as potent anticancer agents - Synthesis, molecular structure, QSAR studies and metabolic stability.
A. Pogorzelska (2017)
Synthesis of 2-alkylthio-N-(quinazolin-2-yl)benzenesulfonamide derivatives: anticancer activity, QSAR studies, and metabolic stability
A. Pogorzelska (2018)
Synthesis of a new series of biologically interesting 6′-chloro-1′,1′-dioxospiro[4H-benzo[d][1,3,7]oxadiazocine-4,3′(2′H)-[1,4,2]benzodithiazine]-2,6(1H,5H)dione derivatives
Z. Brzozowski (2013)